My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.3869 +0.0081 (+2.14%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Sangamo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Deep Dive Into Sangamo Therapeutics Stock: Analyst Perspectives (4 Ratings) ↗

January 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 10, 2024

Via Benzinga

Where Sangamo Therapeutics Stands With Analysts ↗

November 06, 2023

Via Benzinga

What 8 Analyst Ratings Have To Say About Sangamo Therapeutics ↗

November 06, 2023

Via Benzinga

What To Know About RBC Capital's Downgrade of Sangamo Therapeutics ↗

November 03, 2023

Via Benzinga

Analyst Ratings for Sangamo Therapeutics ↗

August 15, 2023

Via Benzinga

A Preview Of Sangamo Therapeutics's Earnings ↗

August 07, 2023

Via Benzinga

The Latest Analyst Ratings for Sangamo Therapeutics ↗

May 01, 2023

Via Benzinga

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 15, 2023

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 31, 2023

Via Benzinga

Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 28, 2023

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.

Via Benzinga

Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 02, 2023

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.

Via Benzinga

Sangamo Therapeutics's Return On Capital Employed Overview ↗

May 01, 2023

Via Benzinga

Sangamo Therapeutics's Earnings Outlook ↗

April 25, 2023

Via Benzinga

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 05, 2023

On Thursday, 369 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases ↗

August 25, 2023

Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

August 18, 2023

We're starting the final day of trading this week with a dive into the biggest pre-market stock movers worth watching for Friday!

Via InvestorPlace

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May ↗

May 11, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 ↗

April 28, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 31, 2023

During Wednesday's session, 212 companies made new 52-week lows.

Via Benzinga

Soon After Novartis & Biogen Walked Away From Neurology Drug Partnerships, Sangamo Announces Major Restructuring ↗

April 27, 2023

Sangamo Therapeutics Inc (NASDAQ: SGMO) announced cutting 27% of its workforce, prioritizing its pipeline, and changing its corporate structure to save about $31 million to fund operations for at least...

Via Benzinga

This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March? ↗

April 19, 2023

A company that seems to have seen poor market sentiment lately is NanoViricides Inc. (NYSEAMERICAN: NNVC), a pharmaceutical company specializing in the development of nanomedicine drugs for treating...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 08, 2023

On Monday, 61 companies hit new 52-week lows.

Via Benzinga

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗

April 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Via InvestorPlace

Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 14, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 10, 2023

Monday's session saw 114 companies set new 52-week lows.

Via Benzinga

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.